The store will not work correctly when cookies are disabled.
ethyl 6-methoxy-4-(phenyltellanyl)quinoline-2-carboxylate
ID: ALA4634988
PubChem CID: 156014170
Max Phase: Preclinical
Molecular Formula: C19H17NO3Te
Molecular Weight: 434.95
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc([Te]c2ccccc2)c2cc(OC)ccc2n1
Standard InChI: InChI=1S/C19H17NO3Te/c1-3-23-19(21)17-12-18(24-14-7-5-4-6-8-14)15-11-13(22-2)9-10-16(15)20-17/h4-12H,3H2,1-2H3
Standard InChI Key: NDZQKYKMNNNOFZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
15.6738 -2.8643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6727 -3.6838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3807 -4.0928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3789 -2.4554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0875 -2.8607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0883 -3.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7968 -4.0867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5051 -3.6759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5004 -2.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7912 -2.4504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7985 -4.9039 0.0000 Te 0 0 0 0 0 2 0 0 0 0 0 0
18.5071 -5.3111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5054 -6.1259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2132 -6.5329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9210 -6.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9167 -5.3014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2084 -4.8981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2056 -2.4409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9157 -2.8452 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2006 -1.6237 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6210 -2.4323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3311 -2.8366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9646 -4.0918 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2572 -3.6827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 1 0
2 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 434.95 | Molecular Weight (Monoisotopic): 437.0271 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |